Company Filing History:
1 out of 57 
1 out of 163 
Years Active: 2024
Title: Julia Dannenmaier: Innovator in Flavivirus Vaccine Development
Introduction
Julia Dannenmaier is a prominent inventor based in Tübingen, Germany. She has made significant contributions to the field of virology, particularly in the development of vaccines against flavivirus infections. Her innovative work has the potential to impact public health positively.
Latest Patents
Julia Dannenmaier holds 1 patent related to a flavivirus vaccine. The patent focuses on an artificial nucleic acid and a polypeptide that are suitable for the treatment or prevention of infections caused by flaviviruses, such as yellow fever virus and dengue virus. The invention also includes an immunogenic composition and a kit comprising the artificial nucleic acid, polypeptide, or composition. This work aims to provide effective methods for treating or preventing flavivirus-related disorders.
Career Highlights
Throughout her career, Julia has worked with notable companies in the biotechnology sector, including CureVac SE and Sanofi Pasteur Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Julia has collaborated with esteemed colleagues such as Patrick Baumhof and Wolfgang Grosse. These partnerships have enhanced her research and development efforts in the field of vaccine innovation.
Conclusion
Julia Dannenmaier is a key figure in the advancement of flavivirus vaccines, with her innovative patent paving the way for future developments in this critical area of public health. Her contributions reflect the importance of research and collaboration in the fight against infectious diseases.